NEU 0.35% $19.97 neuren pharmaceuticals limited

Current Scenario

  1. 2,830 Posts.
    lightbulb Created with Sketch. 592
    I'm not suggesting this is the current situation, but I can't help thinking it is possible, even probable.

    There is a disconnect between the Board / Management and our largest shareholder. The former want to do a deal (and there have been offers) and LW wants NEU to go it alone. The situation led to the resignation of LW's representative on the Board.

    LW sees considerably more upside than what he would receive from a takeover. He also believes that he is in a position to fund the phase 3 trial.

    So there is an impasse - LW has a blocking vote and the Board cannot do a deal without his approval.
    Last edited by Mr_Cod: 27/03/18
 
watchlist Created with Sketch. Add NEU (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.